Biomerica, Inc.BMRANASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year net income growth rate
Latest
-66100.00%
↓ 3729% below average
Average (39q)
-1726.45%
Historical baseline
Range
High:100.13%
Low:-66100.00%
CAGR
+18.1%
Consistent expansion
| Period | Value |
|---|---|
| Q4 2025 | -66100.00% |
| Q3 2025 | 100.13% |
| Q2 2025 | -32.76% |
| Q1 2025 | -22.42% |
| Q4 2024 | 27.81% |
| Q3 2024 | 7.39% |
| Q2 2024 | 25.91% |
| Q1 2024 | -27.27% |
| Q4 2023 | -33.13% |
| Q3 2023 | 36.84% |
| Q2 2023 | -8.63% |
| Q1 2023 | -1.46% |
| Q4 2022 | 21.52% |
| Q3 2022 | -17.79% |
| Q2 2022 | -1588.64% |
| Q1 2022 | 90.74% |
| Q4 2021 | 27.05% |
| Q3 2021 | -3.17% |
| Q2 2021 | 29.62% |
| Q1 2021 | -23.66% |
| Q4 2020 | 9.21% |
| Q3 2020 | -288.92% |
| Q2 2020 | 43.48% |
| Q1 2020 | -77.42% |
| Q4 2019 | 4.15% |
| Q3 2019 | 35.53% |
| Q2 2019 | -15.70% |
| Q1 2019 | -42.22% |
| Q4 2018 | -5.65% |
| Q3 2018 | 32.34% |
| Q2 2018 | -107.02% |
| Q1 2018 | -20.04% |
| Q4 2017 | -29.75% |
| Q3 2017 | 40.13% |
| Q2 2017 | -13.70% |
| Q1 2017 | -49.91% |
| Q4 2016 | -266.11% |
| Q3 2016 | 95.48% |
| Q2 2016 | -807.90% |
| Q1 2016 | -102.20% |